Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19

References

• Heyman B. Feedback regulation by IgG antibodies. Immunol Lett 2003; 88:157 - 61; http://dx.doi.org/10.1016/S0165-2478(03)00078-6; PMID: 12880686
   PubMed Web of Science ®Google Scholar
• Ravetch JV. Fc receptors. Curr Opin Immunol 1997; 9:121 - 5; http://dx.doi.org/10.1016/S0952-7915(97)80168-9; PMID: 9039776
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8:34 - 47; http://dx.doi.org/10.1038/nri2206; PMID: 18064051
   PubMed Web of Science ®Google Scholar
• Daëron M. Building up the family of ITIM-bearing negative coreceptors. Immunol Lett 1996; 54:73 - 6; http://dx.doi.org/10.1016/S0165-2478(96)02652-1; PMID: 9052857
   PubMed Web of Science ®Google Scholar
• Van den Herik-Oudijk IE, Capel PJ, van der Bruggen T, Van de Winkel JG. Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood 1995; 85:2202 - 11; PMID: 7718892
   PubMed Web of Science ®Google Scholar
• Famiglietti SJ, Nakamura K, Cambier JC. Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis. Immunol Lett 1999; 68:35 - 40; http://dx.doi.org/10.1016/S0165-2478(99)00027-9; PMID: 10397153
   PubMed Web of Science ®Google Scholar
• Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996; 383:263 - 6; http://dx.doi.org/10.1038/383263a0; PMID: 8805703
   PubMed Web of Science ®Google Scholar
• Sármay G, Koncz G, Pecht I, Gergely J. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation. Immunol Lett 1999; 68:25 - 34; http://dx.doi.org/10.1016/S0165-2478(99)00026-7; PMID: 10397152
   PubMed Web of Science ®Google Scholar
• Koncz G, Gergely J, Sármay G. Fc gammaRIIb inhibits both B cell receptor- and CD19-induced Ca2+ mobilization in Fc gammaR-transfected human B cells. Int Immunol 1998; 10:141 - 6; http://dx.doi.org/10.1093/intimm/10.2.141; PMID: 9533441
   PubMed Web of Science ®Google Scholar
• Tedder TF, Isaacs CM. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J Immunol 1989; 143:712 - 7; PMID: 2472450
   PubMed Web of Science ®Google Scholar
• Otero DC, Anzelon AN, Rickert RC. CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 2003; 170:73 - 83; http://dx.doi.org/10.4049/jimmunol.170.1.73; PMID: 12496385
   PubMed Web of Science ®Google Scholar
• Otero DC, Rickert RC. CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition. J Immunol 2003; 171:5921 - 30; http://dx.doi.org/10.4049/jimmunol.171.11.5921; PMID: 14634103
   PubMed Web of Science ®Google Scholar
• Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med 1993; 178:1407 - 17; http://dx.doi.org/10.1084/jem.178.4.1407; PMID: 7690834
   PubMed Web of Science ®Google Scholar
• Tedder TF, Zhou LJ, Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 1994; 15:437 - 42; http://dx.doi.org/10.1016/0167-5699(94)90274-7; PMID: 7524521
   PubMedGoogle Scholar
• Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J Immunol 1999; 162:7088 - 94; PMID: 10358152
   PubMed Web of Science ®Google Scholar
• Karnell JL, Dimasi N, Karnell FG 3rd, Fleming R, Kuta E, Wilson M, Wu H, Gao C, Herbst R, Ettinger R. CD19 and CD32b differentially regulate human B cell responsiveness. J Immunol 2014; 192:1480 - 90; http://dx.doi.org/10.4049/jimmunol.1301361; PMID: 24442430
   PubMed Web of Science ®Google Scholar
• Lazar GA, Dang W, Karki S, Vafa O, Peng JS, Hyun L, Chan C, Chung HS, Eivazi A, Yoder SC, et al. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci U S A 2006; 103:4005 - 10; http://dx.doi.org/10.1073/pnas.0508123103; PMID: 16537476
   PubMed Web of Science ®Google Scholar
• Chu SY, Vostiar I, Karki S, Moore GL, Lazar GA, Pong E, Joyce PF, Szymkowski DE, Desjarlais JR. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies. Mol Immunol 2008; 45:3926 - 33; http://dx.doi.org/10.1016/j.molimm.2008.06.027; PMID: 18691763
   PubMed Web of Science ®Google Scholar
• Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W, et al. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol 2011; 186:4223 - 33; http://dx.doi.org/10.4049/jimmunol.1003412; PMID: 21357255
   PubMed Web of Science ®Google Scholar
• Szili D, Bankó Z, Tóth EA, Nagy G, Rojkovich B, Gáti T, Simon M, Hérincs Z, Sármay G. TGFb activated Kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B Cells. PLoS One 2014; 9:e96381; http://dx.doi.org/10.1371/journal.pone.0096381; PMID: 24801688
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. EudraCT: European Clinical Trials Database; 2013.
   Google Scholar
• Aman MJ, Lamkin TD, Okada H, Kurosaki T, Ravichandran KS. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 1998; 273:33922 - 8; http://dx.doi.org/10.1074/jbc.273.51.33922; PMID: 9852043
   PubMed Web of Science ®Google Scholar
• Tridandapani S, Phee H, Shivakumar L, Kelley TW, Coggeshall KM. Role of SHIP in FcgammaRIIb-mediated inhibition of Ras activation in B cells. Mol Immunol 1998; 35:1135 - 46; http://dx.doi.org/10.1016/S0161-5890(98)00097-2; PMID: 10395202
   PubMed Web of Science ®Google Scholar
• Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2:580 - 92; PMID: 12154377
   PubMed Web of Science ®Google Scholar
• Tarasenko T, Dean JA, Bolland S. FcgammaRIIB as a modulator of autoimmune disease susceptibility. Autoimmunity 2007; 40:409 - 17; http://dx.doi.org/10.1080/08916930701464665; PMID: 17729034
   PubMed Web of Science ®Google Scholar
• Sebbag M, Chapuy-Regaud S, Auger I, Petit-Texeira E, Clavel C, Nogueira L, Vincent C, Cornélis F, Roudier J, Serre G. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Joint Bone Spine 2004; 71:493 - 502; http://dx.doi.org/10.1016/j.jbspin.2004.07.004; PMID: 15589429
   PubMed Web of Science ®Google Scholar
• Yamada R, Suzuki A, Chang X, Yamamoto K. Citrullinated proteins in rheumatoid arthritis. Front Biosci 2005; 10:54 - 64; http://dx.doi.org/10.2741/1506; PMID: 15574347
   PubMed Web of Science ®Google Scholar
• Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68:736 - 43; http://dx.doi.org/10.1136/ard.2008.091355; PMID: 18635594
   PubMed Web of Science ®Google Scholar
• Peng SL. Signaling in B cells via Toll-like receptors. Curr Opin Immunol 2005; 17:230 - 6; http://dx.doi.org/10.1016/j.coi.2005.03.003; PMID: 15886111
   PubMed Web of Science ®Google Scholar
• Ries M, Schuster P, Thomann S, Donhauser N, Vollmer J, Schmidt B. Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation. J Leukoc Biol 2013; 94:123 - 35; http://dx.doi.org/10.1189/jlb.0612278; PMID: 23610148
   PubMed Web of Science ®Google Scholar
• Meyer-Bahlburg A, Rawlings DJ. B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev 2008; 7:313 - 6; http://dx.doi.org/10.1016/j.autrev.2007.11.027; PMID: 18295736
   PubMed Web of Science ®Google Scholar
• Kenny EF, Quinn SR, Doyle SL, Vink PM, van Eenennaam H, O’Neill LA. Bruton’s tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin. PLoS One 2013; 8:e74103; http://dx.doi.org/10.1371/journal.pone.0074103; PMID: 23967355
   PubMed Web of Science ®Google Scholar
• Otero DC, Omori SA, Rickert RC. CD19-dependent activation of Akt kinase in B-lymphocytes. J Biol Chem 2001; 276:1474 - 8; http://dx.doi.org/10.1074/jbc.M003918200; PMID: 11042164
   PubMed Web of Science ®Google Scholar
• Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006; 36:810 - 6; http://dx.doi.org/10.1002/eji.200535744; PMID: 16541472
   PubMed Web of Science ®Google Scholar
• Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, Lipford G, Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3:499; http://dx.doi.org/10.1038/ni0602-499; PMID: 12032557
   PubMed Web of Science ®Google Scholar
• Bellatin MF, Han M, Fallena M, Fan L, Xia D, Olsen N, Branch V, Karp D, Stastny P. Production of autoantibodies against citrullinated antigens/peptides by human B cells. J Immunol 2012; 188:3542 - 50; http://dx.doi.org/10.4049/jimmunol.1100577; PMID: 22345652
   PubMed Web of Science ®Google Scholar
• Szarka E, Babos F, Magyar A, Huber K, Szittner Z, Papp K, et al. Recognition of new citrulline containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of Rheumatoid arthritis patients. Immunology 2013; PMID: 24116744
   PubMed Web of Science ®Google Scholar
• Panayi GS. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?. Rheumatology (Oxford) 2005; 44:Suppl 2 ii3 - 7; http://dx.doi.org/10.1093/rheumatology/keh616; PMID: 15851524
   PubMed Web of Science ®Google Scholar
• Bugatti S, Codullo V, Caporali R, Montecucco C. B cells in rheumatoid arthritis. Autoimmun Rev 2007; 7:137 - 42; http://dx.doi.org/10.1016/j.autrev.2007.02.017; PMID: 18035324
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003; 987:140 - 9; http://dx.doi.org/10.1111/j.1749-6632.2003.tb06042.x; PMID: 12727633
   PubMed Web of Science ®Google Scholar
• Burmester GR, Feist E, Dorner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol 2013.
   Google Scholar
• Keystone EC. B cells in rheumatoid arthritis: from hypothesis to the clinic. Rheumatology (Oxford) 2005; 44:Suppl 2 ii8 - 12; http://dx.doi.org/10.1093/rheumatology/keh617; PMID: 15851525
   PubMedGoogle Scholar
• Looney RJ, Anolik J, Sanz I. B cells as therapeutic targets for rheumatic diseases. Curr Opin Rheumatol 2004; 16:180 - 5; http://dx.doi.org/10.1097/00002281-200405000-00003; PMID: 15103242
   PubMed Web of Science ®Google Scholar
• Brinkman IH, van de Laar MA, Jansen TL, van Roon EN. The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis. Expert Opin Drug Saf 2011; 10:715 - 26; http://dx.doi.org/10.1517/14740338.2011.562188; PMID: 21401437
   PubMed Web of Science ®Google Scholar
• Mattila PK, Feest C, Depoil D, Treanor B, Montaner B, Otipoby KL, Carter R, Justement LB, Bruckbauer A, Batista FD. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity 2013; 38:461 - 74; http://dx.doi.org/10.1016/j.immuni.2012.11.019; PMID: 23499492
   PubMed Web of Science ®Google Scholar
• Callard RE, Rigley KP, Smith SH, Thurstan S, Shields JG. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used. J Immunol 1992; 148:2983 - 7; PMID: 1374445
   PubMed Web of Science ®Google Scholar
• Pezzutto A, Dörken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol 1987; 138:2793 - 9; PMID: 2437199
   PubMed Web of Science ®Google Scholar
• Rigley KP, Callard RE. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4. Eur J Immunol 1991; 21:535 - 40; http://dx.doi.org/10.1002/eji.1830210302; PMID: 1707000
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Poe JC, Satterthwaite AB, Wahl MI, Witte ON, Tedder TF. Complementary roles for CD19 and Bruton’s tyrosine kinase in B lymphocyte signal transduction. J Immunol 2002; 168:5465 - 76; http://dx.doi.org/10.4049/jimmunol.168.11.5465; PMID: 12023340
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Poe JC, Hasegawa M, Tedder TF. CD19 regulates intrinsic B lymphocyte signal transduction and activation through a novel mechanism of processive amplification. Immunol Res 2000; 22:281 - 98; http://dx.doi.org/10.1385/IR:22:2-3:281; PMID: 11339363
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569 - 81; http://dx.doi.org/10.1002/art.27584; PMID: 20872595
   PubMed Web of Science ®Google Scholar
• Biró A, Sármay G, Rozsnyay Z, Klein E, Gergely J. A trypsin-like serine protease activity on activated human B cells and various B cell lines. Eur J Immunol 1992; 22:2547 - 53; http://dx.doi.org/10.1002/eji.1830221013; PMID: 1396962
   PubMed Web of Science ®Google Scholar
• Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109 - 21; http://dx.doi.org/10.1016/0022-1759(83)90308-3; PMID: 6361139
   PubMed Web of Science ®Google Scholar
• Jahnmatz M, Kesa G, Netterlid E, Buisman AM, Thorstensson R, Ahlborg N. Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses. J Immunol Methods 2013; 391:50 - 9; http://dx.doi.org/10.1016/j.jim.2013.02.009; PMID: 23454005
   PubMed Web of Science ®Google Scholar